Endosomal TPC1–mediated Ca <sup>2+</sup> nanodomains regulate transferrin receptor trafficking and iron homeostasis

W William J. Burton (Department of Pharmacology, University of Oxford) A Alice Lin (Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University) A Anthony J. Morgan (Department of Pharmacology, University of Oxford) L Lianne C. Davis (Department of Pharmacology, University of Oxford) C Cheng-Chang Chen (Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University) A Antony Galione (Department of Pharmacology, University of Oxford)

Abstract

Two-pore channel 1 (TPC1) is an endosomal Na + /Ca 2+ -selective channel implicated in membrane trafficking, endosome tubulation, and excitability, but how TPC1 regulates membrane trafficking is unknown. Using TPC1-null human cells, we demonstrate that TPC1 drives transferrin receptor (TfR) trafficking and recycling via Ca 2+ , and not Na + fluxes or endosomal pH changes, since channel-targeted Ca 2+ -buffers inhibited trafficking, whereas a Na + -deficient Ca 2+ -permeable TPC1 mutant fully supported trafficking. TPC1 was unique since other Ca 2+ sources did not support TfR trafficking. TPC1 activity depended on the lipid PI(3,5)P 2 , since trafficking was impaired by a lipid-insensitive TPC1 or inhibitors of lipid synthesis. Finally, a corollary of this reduced TfR trafficking is an iron-deficiency and storage phenotype in TPC1-deficient HeLa cells and mice. Our findings highlight endosomes as unique Ca 2+ stores mobilized by a phosphoinositide-induced TPC1 channel that generates local Ca 2+ nanodomains crucial for maintaining TfR trafficking and consequent iron homeostasis.

Article Details

Volume / Issue Vol. 123, Issue 29
Published July 21, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (6)

W

William J. Burton

Department of Pharmacology, University of Oxford

A

Alice Lin

Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University

A

Anthony J. Morgan

Department of Pharmacology, University of Oxford

L

Lianne C. Davis

Department of Pharmacology, University of Oxford

C

Cheng-Chang Chen

Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University

A

Antony Galione

Department of Pharmacology, University of Oxford